Brown Brothers Harriman & CO Astrazeneca PLC Transaction History

Brown Brothers Harriman & CO

$14 Billion
Q3 2024

A detailed history of Brown Brothers Harriman & CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 6,506 shares of AZN stock, worth $426,988. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,506

Previous 6,062 7.32%

Holding current value

$426,988

Previous $472,000 7.2%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $34,041 - $38,903	444 Added 7.32%	6,506 $506,000
Q2 2024 Aug 09, 2024	BUY	$66.81 - $80.83 $14,430 - $17,459	216 Added 3.69%	6,062 $472,000
Q1 2024 May 10, 2024	SELL	$61.03 - $69.57 $2,380 - $2,713	-39 Reduced 0.66%	5,846 $396,000
Q4 2023 Feb 12, 2024	SELL	$61.89 - $69.28 $40,971 - $45,863	-662 Reduced 10.11%	5,885 $396,000
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $33,268 - $36,782	513 Added 8.5%	6,547 $443,000
Q2 2023 Aug 07, 2023	SELL	$69.91 - $75.81 $37,681 - $40,861	-539 Reduced 8.2%	6,034 $431,000
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $47,741 - $54,129	756 Added 13.0%	6,573 $456,000
Q4 2022 Feb 09, 2023	SELL	$54.21 - $70.44 $29,436 - $38,248	-543 Reduced 8.54%	5,817 $394,000
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $61,821 - $158,284	1,166 Added 22.45%	6,360 $349,000
Q2 2022 Aug 11, 2022	BUY	$59.26 - $71.14 $36,622 - $43,964	618 Added 13.51%	5,194 $343,000
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $220,595 - $265,728	3,959 Added 641.65%	4,576 $304,000
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $24,168 - $26,443	435 Added 239.01%	617 $37,000
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $9,432 - $10,888	-200 Reduced 52.36%	182 $9,000
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $12,421 - $14,853	256 Added 203.17%	382 $19,000
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $2,715 - $3,484	-63 Reduced 33.33%	126 $7,000
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $2,380 - $3,233	63 Added 50.0%	189 $8,000
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $50,357 - $59,845	-1,186 Reduced 90.4%	126 $6,000
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $44,214 - $49,432	1,186 Added 941.27%	1,312 $54,000
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $3,939 - $4,775	-111 Reduced 46.84%	126 $5,000
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $8,238 - $9,413	237 New	237 $9,000

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Astrazeneca PLC Transaction History